EverSource Wealth Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History

EverSource Wealth Advisors’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,265	Closed	-$5.71K	–	4498
2025 Q2	$5.71K	Buy	1,265 +1,221	+2,775%	+$5.49K	﹤0.01%	3104
2025 Q1	$195	Buy	+44	New	+$255	﹤0.01%	3709

Other funds holding YMAB

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EverSource Wealth Advisors's YMAB Position: Q3 2025 in Review

EverSource Wealth Advisors sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 1,265 shares — an estimated $5.71K sold.

EverSource Wealth Advisors first reported a position in YMAB in Q1 2025 and held it in 2 quarters. The position peaked at $5.71K in Q2 2025. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

EverSource Wealth Advisors reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
EverSource Wealth Advisors sold 1,265 Y-mAbs Therapeutics shares in Q3 2025, an estimated $5.71K.
EverSource Wealth Advisors first reported a position in Y-mAbs Therapeutics in Q1 2025 and held it in 2 quarters.
EverSource Wealth Advisors's Y-mAbs Therapeutics position peaked at $5.71K in Q2 2025.
2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on EverSource Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.